Nadine Dilong Vaginal rejuvenation is no longer a taboo topic as more and more women opt to treat vaginal concerns such as post-natal laxity, urinary incontinence, dryness, and general discomfort. While as many as half of all women will suffer from one or more of the above concerns in their lifetime, many also wish to treat the external labia, which, until now, was addressed with labiaplasty surgery. Votiva offers a non-surgical alternative to treat both internal as well as external vaginal concerns.
One workstation, three technologies.
InMode’s Votiva offers three treatments in one device: AVIVA, FormaV, and Morpehus 8.
AVIVA:
Promoting women’s health with precision, temperature control and accuracy, Aviva is the minimally invasive solution to vaginal rejuvenation:
- Non-excisional alternative to labiaplasty
- Temperature sensor inside the cannula ensures consistent temperature control during the procedure
- In-office procedure performed under local anaesthesia
FormaV:
FormaV provides customised treatments for patients experiencing changes as a result of ageing, hormonal adjustments or physical damage.
- Provides a solution to sexual dysfunction with temporary relief of minor muscle pain, muscle spasm and an increase in localised blood circulation
- Used internally and externally, showing quick results with continued improvement over time
Morpheus8:
Morpheus8 is a Fractional RF Microneedling technology to effectively remodel the labia, improving overall genitalia aesthetics
- Deepest fractional treatment penetrating up to 4mm with an additional 1mm heat profile
- Extremely uniform effect
- Little to no thermal damage to dermis
- Low-risk of post inflammatory hyperpigmentation
In a recent study published by PRS Gobal Open, patients who underwent treatment with Votiva rated their satisfaction a 9.5/10, with all participants saying they would do it again. In all cases, tightening of the clitoral hood, introitus and forchett were observed, as well as improved distribution of dark pigmentation of the labia minora. Average recovery time was 14 days, and the authors concluded that treatment of labia hyperplasia and laxity with bipolar RF may potentially fill a treatment gap of women seeking aesthetic and functional improvements without surgical labiaplasty.
The Votiva is a clinically proven, efficacious workstation to offer female rejuvenation treatment at your clinic, opening up additional revenue streams with a high ROI.
For more information, visit www.inmode.com.au, email info@inmode.com.au or call (02) 7209 5678.